Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases

Incorporating microarray assessment of HER2 status in clinical practice supports individualised therapy in early-stage breast cancer

(2015) Kathleen A. Grant et al.   BREAST

Evaluation of HER2 Gene Status in Breast Cancer Samples with Indeterminate Fluorescence in Situ Hybridization by Quantitative Real-Time PCR

(2015) Vladimira Koudelakova et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial

(2014) G. Viale et al.   ANNALS OF ONCOLOGY

HER2 testing: Current status and future directions

(2013) Edith A. Perez et al.   CANCER TREATMENT REVIEWS

Droplet Digital PCR Measurement of HER2 Copy Number Alteration in Formalin-Fixed Paraffin-Embedded Breast Carcinoma Tissue

(2013) P. Belgrader et al.   CLINICAL CHEMISTRY

Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions

(2013) Anna Garuti et al.   GYNECOLOGIC ONCOLOGY

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Determination of HER2 Amplification Status on Tumour DNA by Digital PCR

(2013) Isaac Garcia-Murillas et al.   PLoS One

HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?

(2012) M. Iorfida et al.   ANNALS OF ONCOLOGY

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections

(2012) Hiroaki Nitta et al.   Diagnostic Pathology

Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation

(2012) Alexandra S. Whale et al.   NUCLEIC ACIDS RESEARCH

Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches

(2011) J Lehmann-Che et al.   BRITISH JOURNAL OF CANCER

MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab

(2011) N. Nishida et al.   CLINICAL CANCER RESEARCH

Quantitative Reverse Transcriptase Polymerase Chain Reaction and the Oncotype DX Test for Assessment of Human Epidermal Growth Factor Receptor 2 Status: Time to Reflect Again?

(2011) John M.S. Bartlett et al.   JOURNAL OF CLINICAL ONCOLOGY

High False-Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study

(2011) David J. Dabbs et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)

(2010) A. Noske et al.   BREAST CANCER RESEARCH AND TREATMENT

Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories

(2010) Frederick L. Baehner et al.   JOURNAL OF CLINICAL ONCOLOGY

Human Epidermal Growth Factor Receptor 2 Testing: Where Are We?

(2010) Pradip De et al.   JOURNAL OF CLINICAL ONCOLOGY

HER2and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial

(2010) Edith A. Perez et al.   JOURNAL OF CLINICAL ONCOLOGY

Real-Time RT-PCR Analysis for Evaluating the Her2/neu Status in Breast Cancer

(2010) M. Cuadros et al.   PATHOBIOLOGY

Reliability and Reproducibility of a RNA Preamplification Method for Low-density Array Analysis From Formalin-fixed Paraffin-embedded Breast Cancer Samples

(2009) Paola Ciotti et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Preoperative assessment of HER-2/neu status in breast carcinoma: The role of quantitative real-time PCR on core-biopsy specimens

(2009) Tommaso Susini et al.   GYNECOLOGIC ONCOLOGY

Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations

(2009) Guido Sauter et al.   JOURNAL OF CLINICAL ONCOLOGY

Quantitative PCR and HER2 Testing in Breast Cancer

(2008) Massimo Barberis et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Identification of genes for normalization of real-time RT-PCR data in breast carcinomas

(2008) Maria B Lyng et al.   BMC CANCER